This is the authors' abstract. We don't add key points for this paper.
These data suggest that targeting the NPY neural microenvironment may represent a therapeutic approach for the treatment of PCa and resistance through the regulation of multiple oncogenic mechanisms.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: